Praveen Sahu

Mr. Praveen Sahu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
PSPraveen Sahu
Praveen Sahu
Marco BarozziMarco Barozzi
Marco Barozzi
Paolo Di BarbaPaolo Di Barba
Paolo Di Barba
MMMaria Evelina Mognaschi
Maria Evelina Mognaschi
Monica La MuraMonica La Mura
Monica La Mura
Elisabetta SieniElisabetta Sieni
Elisabetta Sieni
Uniform electric field distribution in electroporation is crucial for achieving the effective localized delivery of drug molecules. Currently, in vitro electroporation studies on adherent cells lack a standardized test setup for obtaining consistent and repeatable results, unlike in vitro electroporation studies on cell suspensions that use electroporation cuvettes, which provide uniform electric field distribution. Considering this, we designed, built, and tested a novel inset design for low-volume round well plates, such as the 24- and 96-well plates which are most commonly used in cell culture labs. The inset design was realized using 3D printing and experimentally tested using potato phantoms and HeLa cells. Finite element analysis (FEA) was used to compute the electric field distribution in the round well plates with and without the inset. The FEA indicated that the electric field contour map at the bottom of the well with the inset had a more uniform electric field distribution, with an average value close to the expected 1000 V/cm. In contrast, it was only 840 V/cm without the inset, indicating non-uniform electric field distribution. Uniform electric fields were also obtained using the inset for the potato phantoms and the HeLa cells, indicating the merit of the inset and its usability with low-volume cell culture well plates, which enable the transfer of cells for various assays without additional steps, as well as its cost-effectiveness.

22 April 2024 in arXiv
Verified
Preprint
Open access
PDF file
PSPraveen Sahu
Praveen Sahu
ICIgnacio G. Camarillo
Ignacio G. Camarillo
PGPragatheiswar Giri
Pragatheiswar Giri
RSRaji Sundararajan
Raji Sundararajan
In this research, we investigated the efficacy of Metformin, the most commonly administered type-2 diabetes drug for triple negative breast cancer (TNBC) treatment, due to its various anticancer properties. It is a plant-based bio-compound, synthesized as a novel biguanide, called dimethyl biguanide or metformin. One of the ways it operates is by hindering electron transport chain-complex I, in mitochondria, which causes a drop-in energy (ATP) generation. This eventually builds energetic stress and a decline in energy. Therefore, the natural cellular processes and proliferating tumor cells are obstructed. Here, we used electroporation, where, the MDA-MB-231, human TNBC cells were subjected to high intensity, short-duration electrical pulses (EP) in the presence of Metformin. The cell viability results indicate lower cell viability of 43.45% as compared to 85.20% with drug alone at 5mM concentration. This indicates that Metformin, the most common diabetes drug could also be explored for cancer treatment.